Literature DB >> 18442507

Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review.

Virginia A Stallings1, Lori J Stark, Karen A Robinson, Andrew P Feranchak, Hebe Quinton.   

Abstract

The Cystic Fibrosis Foundation established a process of systematic review of evidence to inform the development of clinical care guidelines and encourage evidence-based practice. The Subcommittee on Growth and Nutrition reviewed the evidence in two areas: energy intake and dosing for pancreatic enzyme replacement therapy. Evidence-based recommendations are presented here. Also, an ad hoc working group conducted a review of the literature and performed new analyses using the Cystic Fibrosis Foundation Patient Registry to update the recommendations for growth and weight-status monitoring. These Registry data-based recommendations are presented.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18442507     DOI: 10.1016/j.jada.2008.02.020

Source DB:  PubMed          Journal:  J Am Diet Assoc        ISSN: 0002-8223


  155 in total

1.  Diagnosing exocrine pancreatic insufficiency after surgery: when and which patients to treat.

Authors:  Helmut Friess; Christoph W Michalski
Journal:  HPB (Oxford)       Date:  2009-12       Impact factor: 3.647

2.  Body composition and lung function in children with cystic fibrosis and meconium ileus.

Authors:  Artemis Doulgeraki; Argyri Petrocheilou; Glykeria Petrocheilou; George Chrousos; Stavros-Eleftherios Doudounakis; Athanasios G Kaditis
Journal:  Eur J Pediatr       Date:  2017-04-13       Impact factor: 3.183

3.  Plasma metabolomics in adults with cystic fibrosis during a pulmonary exacerbation: A pilot randomized study of high-dose vitamin D3 administration.

Authors:  Jessica A Alvarez; Elizabeth Y Chong; Douglas I Walker; Joshua D Chandler; Ellen S Michalski; Ruth E Grossmann; Karan Uppal; Shuzhao Li; Jennifer K Frediani; Rabindra Tirouvanziam; ViLinh T Tran; Vin Tangpricha; Dean P Jones; Thomas R Ziegler
Journal:  Metabolism       Date:  2017-02-11       Impact factor: 8.694

4.  Growth in Prepubertal Children With Cystic Fibrosis Treated With Ivacaftor.

Authors:  Michael S Stalvey; Jesse Pace; Minoo Niknian; Mark N Higgins; Valerie Tarn; Joy Davis; Sonya L Heltshe; Steven M Rowe
Journal:  Pediatrics       Date:  2017-02       Impact factor: 7.124

Review 5.  Developmental and psychosocial issues in cystic fibrosis.

Authors:  Michelle M Ernst; Mark C Johnson; Lori J Stark
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2010-04

6.  Early life growth patterns persist for 12 years and impact pulmonary outcomes in cystic fibrosis.

Authors:  Don B Sanders; Zhumin Zhang; Philip M Farrell; HuiChuan J Lai
Journal:  J Cyst Fibros       Date:  2018-02-01       Impact factor: 5.482

7.  Growth trajectories and oxygen use in neuroendocrine cell hyperplasia of infancy.

Authors:  Rebekah J Nevel; Errine T Garnett; Deneen A Schaudies; Lisa R Young
Journal:  Pediatr Pulmonol       Date:  2018-02-02

8.  Mealtime problems predict outcome in clinical trial to improve nutrition in children with CF.

Authors:  Lisa Opipari-Arrigan; Scott W Powers; Alexandra L Quittner; Lori J Stark
Journal:  Pediatr Pulmonol       Date:  2010-01

9.  Young adults with cystic fibrosis have altered trabecular microstructure by ITS-based morphological analysis.

Authors:  M S Putman; L B Greenblatt; L Sicilian; A Uluer; A Lapey; G Sawicki; C M Gordon; M L Bouxsein; J S Finkelstein
Journal:  Osteoporos Int       Date:  2016-03-07       Impact factor: 4.507

10.  Pubertal height velocity and associations with prepubertal and adult heights in cystic fibrosis.

Authors:  Zhumin Zhang; Mary J Lindstrom; HuiChuan J Lai
Journal:  J Pediatr       Date:  2013-03-25       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.